INDUCTION DE GÈNES DE TRAIL À PETITES MOLÉCULES PAR DES CELLULES NORMALES ET TUMORALES COMME THÉRAPIE ANTICANCÉREUSE

摘要

A pharmaceutical composition, comprising the compound NSC350625, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, for use in a method of treating CNS cancer, lung cancer or lymphoma in a subject.